The eagerly awaited full dataset from the most pivotal pancreatic cancer study in decades didn’t just live up to expectations.It far exceeded them.
June 19, 2026
10 min read
Add topic to email alerts
Receive an email when new articles are posted on
Please provide your email address to receive an email when new articles are posted on .
CHICAGO — The eagerly awaited full dataset from arguably the most pivotal pancreatic cancer trial in decades is now public.Based…
Suneel Kamath, MD, knows too well the sense of helplessness that comes with living through what he calls “the doughnut…
The field is ecstatic about the prospect of a targeted therapy meaningfully extending overall survival in pancreatic cancer.
Highly anticipated data presented at ASCO confirmed what’s been heralded as a medical breakthrough against a historically…
The death rate in the group treated with daraxonrasib was 60% lower than those on chemotherapy. This is hailed as a major advance…
In this episode, Shikha Jain, MD, speaks with Revolution Medicines’ Alan Sandler, MD, about groundbreaking advancements with…
